These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 898120)

  • 1. The treatment of hardness of hearing with origin in the inner ear by means of Xavin.
    Révész G; Ribári O; Zelen B; Stanzel G
    Ther Hung; 1977; 25(2):64-8. PubMed ID: 898120
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of xavin in vascular diseases of the lower extremities].
    Volgin EG
    Klin Med (Mosk); 1980 Oct; 58(10):46-50. PubMed ID: 7442096
    [No Abstract]   [Full Text] [Related]  

  • 4. Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level.
    Pados G; Kusztos D; Németh-Csóka M; Valyon M; Farkas K
    Ther Hung; 1983; 31(2):59-61. PubMed ID: 6571183
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
    Martin G; Jacobs P
    Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):860-3. PubMed ID: 144224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
    Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV
    Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is all chronic neurosensory deafness irreversible?].
    Sala O; Babighian G
    Rev Laryngol Otol Rhinol (Bord); 1972; 93(9):513-22. PubMed ID: 4348366
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease].
    Sivkov II; Kukes VG; Borisov VG; Rudakov MA; Blistanova LS
    Ter Arkh; 1977; 49(1):30-3. PubMed ID: 867235
    [No Abstract]   [Full Text] [Related]  

  • 9. [The conservative treatment of inner ear diseases. A survey of the actual possibilities (author's transl)].
    Tiedemann R
    HNO; 1978 Jul; 26(7):241-3. PubMed ID: 681186
    [No Abstract]   [Full Text] [Related]  

  • 10. [Surheme in the treatment of cochleo-vestibular syndromes of vascular origin].
    Meunier JL; Forestier R
    Ann Otolaryngol Chir Cervicofac; 1973 Jun; 90(6):397-407. PubMed ID: 4541765
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies].
    Dohrmann RE; Kessel ME
    Z Allgemeinmed; 1975 Sep; (26):1167-72. PubMed ID: 1226797
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of ischemic heart disease with complamine].
    Kuz'ko NV
    Vrach Delo; 1981 Jan; (1):82-4. PubMed ID: 7010784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Xanthinol nicotinate and bufenin hydrochloride in the treatment of gestosis].
    Cretti A; Jaworski S
    Ginekol Pol; 1976 Aug; 47(8):909-16. PubMed ID: 971859
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G; Dupont T
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract]   [Full Text] [Related]  

  • 15. Thermographical follow-up during treatment of chronic ulcerations with iontophoresis with xanthinol nicotinate.
    van der Kuy A; Aarts NJ
    Bibl Radiol; 1975; (6):203-9. PubMed ID: 1180851
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE
    Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Klimm HD
    Med Monatsschr; 1976 Apr; 30(4):178-80. PubMed ID: 958145
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of complamin in nephrological practice].
    Mamikonian RS; Barsegian BA; Tumanian AM; Arutiunian VM; Basmadzhian NM
    Zh Eksp Klin Med; 1979; 19(4):62-7. PubMed ID: 506579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of komplamin in chronic ischemic heart disease].
    Serkova VK; Mikunis RI
    Vrach Delo; 1984 Nov; (11):16-8. PubMed ID: 6528554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.